Venge P, Henriksen J, Dahl R, Håkansson L
Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.
J Allergy Clin Immunol. 1990 Feb;85(2):498-504. doi: 10.1016/0091-6749(90)90161-v.
Heat-stable neutrophil chemotactic activity (HS NCA) has been demonstrated in serum of subjects with asthma after exercise and after allergen inhalation challenge. Heat-labile neutrophil chemotactic activity (HL NCA) has been investigated only after allergen inhalation challenge. In this study, we have measured HS NCA and HL NCA after exercise of 22 adult patients with asthma, 13 of whom had exercise-induced asthma (EIA). In the 13 patients, the effect of pharmacologic pretreatment on the generation of HS NCA and EIA was evaluated in a double-blind study with inhalation of either disodium cromoglycate, terbutaline, or budesonide 15 minutes before exercise. Additionally, the effect of 4 weeks of treatment with budesonide aerosol was evaluated in an open study. A significant increase (p less than 0.01) in HS NCA was found in the patients with EIA with peak activities 15 minutes after exercise. In patients without EIA, the activity of HS NCA was variable. No HL NCA was detectable after exercise. EIA was inhibited by disodium chromoglycate, terbutaline, and 4 weeks of treatment with budesonide. The generation of HS NCA was more or less inhibited by all three drugs with 4 weeks of treatment with budesonide as the most potent regimen. No late-phase asthmatic reactions to exercise were found. It is concluded that only HS NCA is generated after exercise of subjects with asthma and that this production is controlled by antiasthmatic drugs. However, the generation of HS NCA occurs irrespective of EIA.
热稳定中性粒细胞趋化活性(HS NCA)已在哮喘患者运动后及吸入变应原激发后的血清中得到证实。热不稳定中性粒细胞趋化活性(HL NCA)仅在吸入变应原激发后进行了研究。在本研究中,我们测定了22例成年哮喘患者运动后的HS NCA和HL NCA,其中13例患有运动诱发性哮喘(EIA)。在这13例患者中,在运动前15分钟吸入色甘酸钠二钠、特布他林或布地奈德的双盲研究中评估了药物预处理对HS NCA产生和EIA的影响。此外,在一项开放性研究中评估了布地奈德气雾剂4周治疗的效果。发现EIA患者运动后15分钟时HS NCA显著增加(p<0.01),活性达到峰值。在无EIA的患者中,HS NCA的活性存在差异。运动后未检测到HL NCA。色甘酸钠二钠、特布他林和布地奈德4周治疗均可抑制EIA。三种药物对HS NCA的产生均或多或少有抑制作用,其中布地奈德4周治疗最为有效。未发现运动诱发的迟发性哮喘反应。结论是,哮喘患者运动后仅产生HS NCA,且这种产生受抗哮喘药物控制。然而,HS NCA的产生与EIA无关。